Mild traumatic brain injury (mTBI), commonly known as a concussion, has been increasingly studied for its potential long-term effects on cognitive health, including the risk of developing dementia. Here is a comprehensive overview of the current understanding based on recent research.
Risk of Dementia After Mild Traumatic Brain Injury (mTBI) Read Post »
Concussions and post-concussion symptoms significantly impact the brain’s ability to process and integrate sensory information, leading to a phenomenon termed “internal fake news.” This occurs when altered sensory perceptions distort internal models, affecting decision-making and leading to a cascade of negative consequences including chronic stress, anxiety, and depression. The cerebellum’s role in integrating multisensory information is crucial for updating these internal models accurately. Disruptions in this process, commonly seen in concussion patients, result in a vicious cycle of emotional disturbances. Early intervention and a multidisciplinary approach are essential for mitigating these effects and supporting recovery.
The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a vital tool in the assessment of concussions, providing objective data on cognitive function and symptomatology. This article explores how ImPACT can differentiate between symptoms originating from concussions, psychological conditions, and malingering. Through cognitive assessments, symptom tracking, baseline comparisons, and validity indicators, ImPACT aids clinicians in distinguishing between these conditions. However, it emphasizes that ImPACT should be part of a comprehensive clinical evaluation for accurate diagnosis and effective management.
Several studies have demonstrated that elevated levels of S100B, GFAP, UCH-L1, and NFL correlate with the presence and severity of mTBI. S100B, a marker of astrocytic damage, has been shown to have high sensitivity but moderate specificity for mTBI. GFAP, another astrocytic marker, exhibits higher specificity and is particularly useful in differentiating mTBI from other conditions. UCH-L1, a marker of neuronal cell body injury, and NFL, indicative of axonal damage, both show promise in reflecting the extent of neuronal injury and predicting recovery outcomes. Additionally, combinations of these biomarkers may enhance diagnostic accuracy and provide more comprehensive insights into the injury mechanisms and prognosis.
The use of blood biomarkers in mTBI offers several advantages, including non-invasiveness, rapid turnaround time, and the potential for point-of-care testing. However, challenges such as variability in biomarker levels due to individual differences, the influence of extracranial injuries, and the need for standardized protocols must be addressed. Further research is required to validate these biomarkers in larger, diverse populations and to establish clear clinical guidelines for their use.
Blood biomarkers in mTBI Read Post »
Foreign Accent Syndrome (FAS) is an uncommon speech disorder where individuals develop a new, seemingly foreign accent in their native language. This review explores FAS within the contexts of functional neurological disorders (FND) and mild traumatic brain injuries (mTBIs).
In FNDs, FAS is often classified as a functional speech disorder, where no definitive structural brain lesions or neurological causes are identified. Cases suggest a psychogenic or functional origin, possibly triggered by psychological stress. Studies highlight that FAS in FNDs features inconsistencies and intermittency in speech patterns, which can occur even in the presence of structural brain damage.
In mTBIs, FAS can emerge without significant structural lesions visible on imaging. Reports indicate that even minor head injuries might lead to FAS, with functional or metabolic brain changes undetected by standard imaging techniques. For instance, abnormal functions in specific brain regions, such as the left dorsolateral inferior frontal gyrus and caudate nucleus, have been implicated.
Overall, the occurrence of FAS in both FNDs and post-mTBI contexts underscores the complexity of this speech disorder and the need for integrated diagnostic and therapeutic approaches. The studies reviewed suggest that functional and metabolic assessments, alongside behavioural interventions, are crucial for understanding and managing FAS effectively.
Foreign Accent Syndrome Read Post »
Functional Neurological Disorders (FND) present with symptoms that lack clear organic causes and mimic other neurological disorders. This overlap complicates diagnosis and significantly increases the likelihood of misdiagnosis. Traditionally considered a diagnosis of exclusion, the approach to FND has shifted towards inclusion based on specific clinical indicators. Despite advancements in diagnostic techniques and a growing understanding of FND’s pathophysiology, misdiagnoses remain common. These are often exacerbated by persistent misconceptions, such as viewing FND as solely psychological or suspecting symptom feigning. Misdiagnoses lead to inappropriate treatments, which are costly, potentially harmful, and psychologically damaging to patients. This paper reviews the challenges and impacts of FND misdiagnosis, emphasizes the importance of an informed, multidisciplinary approach for accurate diagnosis, and suggests advancements in neuroimaging and clinical education as critical tools for improvement.
Misdiagnosis in Functional Neurological Disorders (FND) Read Post »
he diagnosis of Functional Neurological Disorder (FND) represents a challenging but critical endeavor in neurology and psychiatry, requiring an integrated approach that transcends traditional diagnostic categories. This paper outlines a comprehensive framework for diagnosing FND, emphasizing the importance of direct clinical assessment, the strategic exclusion of other neurological and medical conditions, and the identification of characteristic positive signs. Contrary to being a diagnosis of exclusion, FND involves specific, identifiable signs such as Hoover’s sign, distractibility, and other non-physiological findings. These markers facilitate a positive diagnostic outcome, reinforcing that FND symptoms are genuine and rooted in functional impairments rather than structural abnormalities. Furthermore, the method of communicating the diagnosis to patients significantly affects their understanding, acceptance, and engagement in subsequent treatment, which can include physical therapy, psychotherapy, and medication. By providing a clear diagnostic pathway that incorporates both neurologic and psychiatric expertise, this paper aims to enhance the accuracy of FND diagnoses and improve patient outcomes through tailored, multidisciplinary care.
Diagnosis of functional neurological disorder Read Post »
Functions of the Olfactory Nerve The primary function of the olfactory nerve is to convey sensory information related to smell
Functions of the Olfactory Nerve and Analysis of Olfactory Processes into the Brain Read Post »
Anatomy of the Second Cranial Nerve The second cranial nerve, also known as the optic nerve, is a pivotal component
Anatomy of the optic nerve and the visual pathway Read Post »
Functional cognitive impairment (FCI) post-mild traumatic brain injury (mTBI) presents a significant challenge, often manifesting subtle symptoms that persist well beyond the healing of physical injuries. The primary causative factor is the brain trauma itself, which disrupts normal cognitive functioning and is exacerbated by metacognitive impairments, psychological factors such as depression and anxiety, and physical symptoms like fatigue and headache. Despite normal results on traditional neuropsychological tests, affected individuals may struggle with daily cognitive tasks, impacting their quality of life. While treatment options like transcranial Direct Current Stimulation (tDCS) and cognitive rehabilitation programs show promise, the prognosis for FCI varies widely, dependent on several factors including the severity of the initial injury and individual health conditions. Emerging research using techniques like [18F]fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) offers new insights into prognosis, enhancing understanding and management of FCI.
Functional Cognitive Impairment Following Mild Traumatic Brain Injury (mTBI) Read Post »
